A Trial of HTI-1090 in Subjects With Advanced Solid Tumors
NCT03208959
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
HTI-1090
Sponsor
Atridia Pty Ltd.